The PDF brochure for the 4th Rare Disease Market Access & Commercialization Summit is now available. Download it now

50+ Pharma and Advocacy Leaders are Registered to Attend. Shouldn’t you be there? Reserve your seat today!

Featured Speakers

Top 5 Reasons to Attend

  • Learn from industry leaders successful examples of bringing a rare disease product to market through detailed case studies
  • Gain perspective from the expanding patient voice, including the effects of patient-reported outcomes on determining a product’s true value
  • Network with multiple stakeholders all trying to achieve the same goal of getting therapies to patients who need them -- Pharma, biotech, payers, providers, and advocacy leaders, as well as service providers to form mutually beneficial, lasting partnerships
  • Discuss common challenges in rare disease operations and acquire best practices for ensuring market access
  • Examine the correlation between a limited patient base, vitality of a particular drug, and the economic implications of getting a product to market


Excellent multi-disciplinary expertise and a robust exchange of best practices

–Haya Taitel, Senior Vice President, Marketing, Kadmon

Participating Organizations

Executive Sponsors